NASDAQ: PLSE - Pulse Biosciences, Inc.

Yield per half year: +57.93%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Pulse Biosciences, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Pulse Biosciences, Inc.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2016-05-18
ISIN US74587B1017
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.pulsebiosciences.com
Цена ао 8.25
Change price per day: -3.79% (18.73)
Change price per week: +0.2225% (17.98)
Change price per month: -11.54% (20.37)
Change price per 3 month: +4.74% (17.205)
Change price per half year: +57.93% (11.41)
Change price per year: +47.22% (12.24)
Change price per 3 year: +11.58% (16.15)
Change price per 5 year: +31.73% (13.68)
Change price per 10 year: 0% (18.02)
Change price per year to date: +11.79% (16.12)
All parameters

Underestimation

Title Value Grade
P/S -67573.45 0
P/BV 13.71 1
P/E 0 0
EV/EBITDA -13.52 0
Total: 1.88

Efficiency

Title Value Grade
ROA, % -69.42 0
ROE, % -95.15 0
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.2158 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % -103.64 0
Yield Ebitda, % -9.47 0
Yield EPS, % -60.42 0
Total: 0
More

Institutions Volume Share, %
Blackrock Inc. 1071736 1.94
Bank of America Corporation 801341 1.45
Vanguard Group Inc 657985 1.19
Geode Capital Management, LLC 379259 0.69
State Street Corporation 309520 0.56
Griffin Asset Management, Inc. 259620 0.47
Northern Trust Corporation 183665 0.33
Spotlight Asset Group, Inc. 72090 0.13
Bank Of New York Mellon Corporation 46129 0.08
Morgan Stanley 45438 0.08

ETF Share, % Profitability for 1 year, % Dividends, %
Inspire Small/Mid Cap ETF 0.30561 28.65 1.92038
iShares Micro-Cap ETF 0.08306 17.09 1.54048
Vanguard Russell 2000 Growth ETF 0.03 23.05 0.60264
iShares Russell 2000 Growth ETF 0.02505 38.04 0.6026
Vanguard Russell 2000 ETF 0.01 17.16 1.48801
ProShares UltraPro Russell2000 0.00707 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.00566 3 1.46057
ProShares Hedge Replication ETF 0.00215 5.92 1.47892
iShares Russell 3000 ETF 0.00113 24.83 1.43482
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Mr. Robert W. Duggan Executive Co-Chairman N/A 1944 (81 year)
Mr. Darrin R. Uecker CTO & Director 834.73k 1966 (59 years)
Mr. Mitchell E. Levinson Chief Strategy Officer 584.57k 1960 (65 years)
Dr. Richard Nuccitelli Ph.D. Chief Science Officer N/A
Mr. Kenneth B. Stratton Esq., J.D. General Counsel & Corporate Secretary N/A 1969 (56 years)
Ms. Patty Perla Vice President of Human Resources N/A
Mr. David Danitz Senior Vice President of Engineering N/A
Mr. Kevin P. Danahy Chief Commercial Officer 1971 (54 years)
Mr. Burke T. Barrett President, CEO & Director 1964 (61 year)
Mr. Edison Manuel Vice President of Operations

Address: United States, Hayward. CA, 3957 Point Eden Way - open in Google maps, open in Yandex maps
Website: https://www.pulsebiosciences.com